Last 21.70 INR
Change Today +0.35 / 1.64%
Volume 12.1K
As of 11:00 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for jagsonpal pharmaceuticals (JGPH)

Year over year, JAGSONPAL Pharmaceuticals Ltd has seen revenues shrink from 1.7B INR to 1.4B INR, though the company was able to grow net income from 18.3M INR to 21.2M INR. A reduction in the percentage of sales devoted to cost of goods sold from 54.50% to 47.62% was a key component in the bottom line growth in the face of falling revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2011
Restated
INR
Mar 31
2012
Restated
INR
Mar 31
2013
Restated
INR
Mar 31
2014
INR
4 Year
Trend
Revenues1,609.61,765.11,664.61,438.5
Other Revenues----0.00.0
TOTAL REVENUES1,609.61,765.11,664.61,438.5
Cost of Goods Sold865.7881.1907.2685.1
GROSS PROFIT743.9884.1757.4753.4
Selling General & Admin Expenses, Total546.4655.8615.0605.0
Depreciation & Amortization, Total22.025.427.128.3
Other Operating Expenses52.162.041.841.6
OTHER OPERATING EXPENSES, TOTAL620.5743.1683.9674.8
OPERATING INCOME123.4140.973.578.6
Interest Expense-31.5-41.1-49.0-50.1
Interest and Investment Income0.30.50.30.6
NET INTEREST EXPENSE-31.1-40.6-48.6-49.5
Other Non-Operating Income (Expenses)0.40.60.5-3.8
EBT, EXCLUDING UNUSUAL ITEMS92.7100.925.425.3
EBT, INCLUDING UNUSUAL ITEMS92.7100.925.425.3
Income Tax Expense20.926.37.04.1
Earnings from Continuing Operations71.874.618.321.2
NET INCOME71.874.618.321.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS71.874.618.321.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS71.874.618.321.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JGPH:IN 21.70 INR +0.35

JGPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JGPH.
View Industry Companies
 

Industry Analysis

JGPH

Industry Average

Valuation JGPH Industry Range
Price/Earnings 19.4x
Price/Sales 0.4x
Price/Book 0.6x
Price/Cash Flow 9.7x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAGSONPAL PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.